XML 28 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Preferred and Common Shares and Share-Based Compensation
3 Months Ended
Mar. 29, 2024
Share-Based Payment Arrangement [Abstract]  
Preferred and Common Shares and Share-Based Compensation

12. Preferred and Common Shares and Share-Based Compensation

Preferred Shares

In May 2021, the Company’s shareholders approved a special resolution to amend the Company’s articles to authorize up to 7.0 million preferred shares for future issuance. The Company’s Board of Directors is authorized to designate and issue one or more series of preferred shares, fix the rights, preferences and designation, as deemed necessary or advisable, relating to the preferred shares, provided that no shares of any series may be entitled to more than one vote per share. As of March 29, 2024, no preferred shares had been issued and outstanding.

Common Share Repurchases

In February 2020, the Company’s Board of Directors approved a share repurchase plan (the “2020 Repurchase Plan”), authorizing the repurchase of $50.0 million worth of the Company’s common shares. During 2022, the Company repurchased 4 thousand shares under the 2020 Repurchase Plan for an aggregate purchase price of $0.5 million and an average price of $116.95 per share. During the three months ended March 29, 2024, the Company did not repurchase any shares. As of March 29, 2024, the Company had $49.5 million available for future share repurchases under the 2020 Repurchase Plan.

Share-Based Compensation Expense

The table below summarizes share-based compensation expense recorded in the consolidated statements of operations (in thousands):

 

Three Months Ended

 

 

March 29,

 

 

March 31,

 

 

2024

 

 

2023

 

Selling, general and administrative

$

5,097

 

 

$

5,531

 

Research and development and engineering

 

559

 

 

 

443

 

Cost of revenue

 

421

 

 

 

492

 

Total share-based compensation expense

$

6,077

 

 

$

6,466

 

Share-based compensation expense reported in selling, general and administrative expenses included expenses related to restricted stock units and deferred stock units granted to the members of the Company’s Board of Directors of $1.4 million and $0.9 million during the three months ended March 29, 2024 and March 31, 2023, respectively.

Restricted Stock Units

The Company’s restricted stock units (“RSUs”) have generally been issued with vesting periods ranging from zero to five years and vest based solely on service conditions. Accordingly, the Company recognizes compensation expense on a straight-line basis

over the requisite service period. The Company reduces the compensation expense by an estimated forfeiture rate which is based on anticipated forfeitures and historical forfeiture experience.

The table below summarizes activities relating to RSUs issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the three months ended March 29, 2024:

 

 

Shares
(In thousands)

 

 

Weighted
Average Grant
Date Fair Value

 

Unvested at December 31, 2023

 

206

 

 

$

143.97

 

Granted

 

90

 

 

$

158.46

 

Vested

 

(89

)

 

$

140.63

 

Forfeited

 

(2

)

 

$

154.72

 

Unvested at March 29, 2024

 

205

 

 

$

151.66

 

Expected to vest as of March 29, 2024

 

180

 

 

 

 

 

The total fair value of RSUs that vested during the three months ended March 29, 2024 was $14.1 million based on the market price of the underlying shares on the date of vesting.

Performance Stock Units

The Company typically grants PSUs that are based on the Company’s financial metrics, market conditions, or a hybrid of company financial metrics and market conditions. These PSUs generally cliff vest on the first day following the end of the specified performance period.

The number of common shares to be issued upon settlement following vesting of attainment-based PSUs is determined based on the Company’s financial metrics over the specified performance period against the targets established by the Company’s Board of Directors at the time of grant and will be in the range of zero to 200% of the target number of shares. The Company recognizes the related compensation expense ratably over the performance period based on the number of shares that are deemed probable of vesting at the end of the specified performance period. This probability assessment is performed quarterly and the cumulative effect of a change in the estimated compensation expense, if any, is recognized in the consolidated statement of operations in the period in which such determination is made.

The number of common shares to be issued upon settlement following vesting of market-based PSUs is determined based on the relative market performance of the Company’s common stock compared to the Russell 2000 Index over the specified performance period using a payout formula established by the Company’s Board of Directors at the time of grant and will be in the range of zero to 200% of the target number of shares. The Company recognizes the related compensation expense based on the fair value of the market-based PSUs, determined using the Monte-Carlo valuation method as of the grant date, on a straight-line basis from the grant date to the end of the specified performance period. Compensation expense on market-based PSUs will not be affected by the number of shares that will ultimately vest at the end of the specified performance period.

The number of common shares to be issued upon settlement following vesting of PSU awards that are based on the achievement of a hybrid of company financial metrics and market conditions (“Hybrid PSUs”) is determined based on the Company's financial metrics achieved over the specified performance period against the targets established by the Company's Board of Directors at the time of grant and a market-based multiplier based on the relative market performance of the Company’s common stock compared to the Russell 2000 Index. The payout will be in the range of zero to 260% of the target number of shares. The Company determines the fair value of these Hybrid PSUs using the Monte-Carlo valuation method as of the grant date. The Company recognizes compensation expense associated with the Hybrid PSUs ratably over the performance period based on the fair value of the PSUs as of the grant date and the number of shares that are deemed probable of vesting based on the estimated achievement of the pertinent company financial metrics at the end of the specified performance period. The probability assessment is performed quarterly and the cumulative effect of a change in the estimated compensation expense, if any, is recognized in the consolidated statement of operations in the period in which such determination is made.

The table below summarizes the activities relating to the performance-based awards issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the three months ended March 29, 2024:

 

 

Shares
(In thousands)

 

 

Weighted
Average Grant-
Date Fair Value

 

Unvested at December 31, 2023

 

205

 

 

$

160.24

 

Granted

 

80

 

 

$

177.06

 

Performance adjustments(1)

 

16

 

 

$

166.64

 

Vested

 

(45

)

 

$

168.60

 

Forfeited

 

(2

)

 

$

172.12

 

Unvested at March 29, 2024

 

254

 

 

$

165.11

 

Expected to vest as of March 29, 2024

 

243

 

 

 

 

(1) The amount shown represents performance adjustments related to the performance-based awards vested during the three months ended March 29, 2024.

The unvested PSUs are shown at target payout levels in the table above. As of March 29, 2024, the maximum number of common shares that could be earned under these PSU grants was approximately 485 thousand shares.

The total fair value of PSUs that vested during the three months ended March 29, 2024 was $7.5 million based on the market price of the underlying common shares on the date of vesting.

The grant-date fair value per unit of the hybrid PSUs granted during the three months ended March 29, 2024 was estimated using the Monte Carlo valuation method with the following assumptions:

 

 

Three Months Ended
March 29, 2024

 

Grant-date stock price

$

157.48

 

Expected volatility

 

36.90

%

Risk-free interest rate

 

4.35

%

Expected annual dividend yield

 

 

Fair value

$

180.98

 

Stock Options

In February 2024, the Company granted 53 thousand nonqualified stock options to certain members of the executive management team to purchase common shares of the Company at a strike price equal to the closing market price on the date of grant. The stock options vest ratably over three years on the anniversary of the date of grant and expire on the seventh anniversary of the date of grant. The Company estimates the fair value of stock options using the Black-Scholes valuation model. The Company recognizes compensation expense related to the stock options on a straight-line basis over the vesting period in the consolidated statement of operations.

The table below summarizes the activities relating to stock options issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the three months ended March 29, 2024:

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares
(In thousands)

 

 

Weighted
Average Exercise Price

 

Outstanding as of December 31, 2023

 

132

 

 

$

102.86

 

Granted

 

53

 

 

$

157.48

 

Exercised

 

 

 

$

 

Forfeited or expired

 

 

 

$

 

Outstanding as of March 29, 2024

 

185

 

 

$

118.57

 

Exercisable as of March 29, 2024

 

87

 

 

 

 

Expected to vest as of March 29, 2024

 

98

 

 

 

 

The aggregate Black-Scholes fair value of $3.3 million for the stock options granted during the three months ended March 29, 2024 was estimated using the following assumptions as of the grant date:

 

Three Months Ended
March 29, 2024

 

Expected option term in years

 

4.5

 

Expected volatility

 

40.3

%

Risk-free interest rate

 

4.2

%

Expected annual dividend yield

 

 

The expected option term was calculated using the simplified method permitted under Codification of Staff Accounting Bulletins Topic 14, “Share-Based Payment”. The expected volatility was determined based on the historical volatility of the Company’s common shares over the expected option term. The risk-free interest rate was based on treasury instrument whose term was six months longer than the expected option term. The expected annual dividend yield is zero as the Company does not have plans to issue dividends.